IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 316 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $10,522,017 | -36.9% | 220,518 | -37.5% | 0.00% | -40.0% |
Q1 2024 | $16,670,651 | +47.4% | 352,818 | +57.9% | 0.01% | +66.7% |
Q4 2023 | $11,310,185 | +12.2% | 223,389 | -1.5% | 0.00% | 0.0% |
Q3 2023 | $10,077,658 | -13.8% | 226,821 | -19.3% | 0.00% | -25.0% |
Q2 2023 | $11,689,427 | +15.1% | 281,131 | -1.0% | 0.00% | 0.0% |
Q1 2023 | $10,159,052 | -18.7% | 283,931 | -5.7% | 0.00% | -20.0% |
Q4 2022 | $12,497,748 | -30.7% | 301,078 | -21.9% | 0.01% | -37.5% |
Q3 2022 | $18,022,000 | +95.5% | 385,729 | +66.3% | 0.01% | +100.0% |
Q2 2022 | $9,220,000 | -3.8% | 231,992 | -13.6% | 0.00% | -20.0% |
Q1 2022 | $9,583,000 | +33.7% | 268,497 | +17.0% | 0.01% | +25.0% |
Q4 2021 | $7,167,000 | -15.6% | 229,407 | -8.1% | 0.00% | 0.0% |
Q3 2021 | $8,493,000 | -43.8% | 249,704 | -34.5% | 0.00% | -50.0% |
Q2 2021 | $15,111,000 | +9.9% | 381,485 | +18.4% | 0.01% | -11.1% |
Q1 2021 | $13,755,000 | -36.3% | 322,230 | -7.3% | 0.01% | -35.7% |
Q4 2020 | $21,589,000 | +42.6% | 347,644 | +4.0% | 0.01% | +7.7% |
Q3 2020 | $15,137,000 | -35.2% | 334,172 | -13.6% | 0.01% | -38.1% |
Q2 2020 | $23,370,000 | +40.1% | 386,670 | +13.6% | 0.02% | +10.5% |
Q1 2020 | $16,684,000 | +769.9% | 340,444 | +972.4% | 0.02% | +1800.0% |
Q4 2019 | $1,918,000 | +24.6% | 31,746 | +23.6% | 0.00% | 0.0% |
Q3 2019 | $1,539,000 | -3.5% | 25,688 | +3.5% | 0.00% | 0.0% |
Q2 2019 | $1,595,000 | -40.7% | 24,826 | -25.1% | 0.00% | -50.0% |
Q1 2019 | $2,689,000 | +39.5% | 33,136 | -7.1% | 0.00% | 0.0% |
Q4 2018 | $1,928,000 | +104.7% | 35,651 | +95.2% | 0.00% | +100.0% |
Q3 2018 | $942,000 | +19.4% | 18,265 | -3.6% | 0.00% | 0.0% |
Q2 2018 | $789,000 | +1.3% | 18,950 | +7.3% | 0.00% | 0.0% |
Q1 2018 | $779,000 | -2.1% | 17,662 | +11.8% | 0.00% | 0.0% |
Q4 2017 | $796,000 | -39.2% | 15,801 | -38.8% | 0.00% | 0.0% |
Q3 2017 | $1,309,000 | +407.4% | 25,818 | +409.1% | 0.00% | – |
Q2 2017 | $258,000 | +6.6% | 5,071 | -15.4% | 0.00% | – |
Q1 2017 | $242,000 | -22.7% | 5,997 | -16.0% | 0.00% | – |
Q4 2016 | $313,000 | +63.9% | 7,142 | +36.8% | 0.00% | – |
Q3 2016 | $191,000 | -51.5% | 5,222 | -69.1% | 0.00% | – |
Q2 2016 | $394,000 | -42.2% | 16,893 | +0.4% | 0.00% | -100.0% |
Q1 2016 | $682,000 | -35.7% | 16,825 | -1.7% | 0.00% | 0.0% |
Q4 2015 | $1,060,000 | – | 17,114 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bellevue Group AG | 9,347,926 | $313,529,000 | 3.18% |
Sicart Associates LLC | 291,254 | $9,769,000 | 2.66% |
Camber Capital Management LP | 2,500,000 | $83,850,000 | 2.58% |
SECTOR GAMMA AS | 263,870 | $8,850,000 | 1.76% |
Parkman Healthcare Partners LLC | 136,380 | $4,574,000 | 1.16% |
Eversept Partners, LP | 450,501 | $15,109,804 | 1.05% |
SPHERA FUNDS MANAGEMENT LTD. | 350,000 | $11,739,000 | 0.99% |
TANAKA CAPITAL MANAGEMENT INC | 16,661 | $559,000 | 0.80% |
Sonora Investment Management, LLC | 163,703 | $5,491,000 | 0.69% |
ARK Investment Management | 8,511,384 | $285,472,000 | 0.69% |